Acquisition of Cross Vascular to obtain its radiofrequency system for transseptal puncture

An individual M&A theme aimed at accelerating business expansion, including in the United States, by acquiring 100% of Cross Vascular, Inc. in the United States, making it a second-tier subsidiary, and adding its radiofrequency system for transseptal puncture to the global portfolio.